Total Payments
$7,030
2024 Payments
$1,396
Companies
33
Transactions
440
Medicare Patients
7,161
Medicare Billing
$787,258
Payment Breakdown by Category
Food & Beverage$6,831 (97.2%)
Education$198.95 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,831 | 438 | 97.2% |
| Education | $198.95 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,918 | 146 | $0 (2024) |
| Janssen Biotech, Inc. | $832.08 | 44 | $0 (2024) |
| GENZYME CORPORATION | $510.55 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $498.49 | 32 | $0 (2024) |
| Gilead Sciences, Inc. | $416.17 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $359.95 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $270.97 | 6 | $0 (2024) |
| Celgene Corporation | $248.97 | 16 | $0 (2024) |
| Allergan, Inc. | $205.27 | 19 | $0 (2020) |
| INTERCEPT PHARMACEUTICALS, INC. | $186.90 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,396 | 77 | ABBVIE INC. ($370.67) |
| 2023 | $1,420 | 77 | ABBVIE INC. ($366.49) |
| 2022 | $1,163 | 74 | ABBVIE INC. ($362.91) |
| 2021 | $967.74 | 62 | Janssen Biotech, Inc. ($351.98) |
| 2020 | $273.36 | 20 | AbbVie Inc. ($81.68) |
| 2019 | $572.35 | 40 | AbbVie, Inc. ($135.87) |
| 2018 | $504.74 | 34 | AbbVie, Inc. ($278.51) |
| 2017 | $732.83 | 56 | Allergan Inc. ($160.62) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: GI | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.56 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.79 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: GI | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.59 | General |
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,582 | 6,008 | $1.1M | $276,230 |
| 2022 | 25 | 2,033 | 4,355 | $1.1M | $234,522 |
| 2021 | 24 | 2,170 | 2,330 | $1.0M | $164,810 |
| 2020 | 22 | 1,376 | 1,447 | $736,460 | $111,697 |
Total Patients
7,161
Total Services
14,140
Medicare Billing
$787,258
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 181 | 2,775 | $166,500 | $92,885 | 55.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 185 | 1,527 | $114,525 | $67,076 | 58.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 176 | 176 | $255,200 | $32,378 | 12.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 194 | 196 | $166,600 | $13,916 | 8.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $18,200 | $9,910 | 54.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 49 | 294 | $17,640 | $9,732 | 55.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 48 | 255 | $15,300 | $8,792 | 57.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $41,800 | $6,105 | 14.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $51,700 | $5,688 | 11.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 77 | 77 | $111,650 | $5,600 | 5.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $28,600 | $4,355 | 15.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $7,300 | $3,572 | 48.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 34 | $5,780 | $3,280 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 38 | $5,410 | $3,178 | 58.7% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $18,000 | $2,610 | 14.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 79 | 80 | $16,000 | $2,292 | 14.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 43 | $2,985 | $1,583 | 53.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $1,580 | $736.44 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,310 | $671.07 | 51.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 63 | 79 | $1,065 | $621.60 | 58.4% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 28 | 28 | $1,680 | $574.29 | 34.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 34 | 34 | $1,020 | $421.08 | 41.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 77 | 79 | $1,185 | $253.59 | 21.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 194 | 1,703 | $102,180 | $59,131 | 57.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 194 | 932 | $69,900 | $42,878 | 61.3% |
About Dr. Samuel Johnson, MD
Dr. Samuel Johnson, MD is a Specialist healthcare provider based in Columbus, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083638217.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Johnson, MD has received a total of $7,030 in payments from pharmaceutical and medical device companies, with $1,396 received in 2024. These payments were reported across 440 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,831).
As a Medicare-enrolled provider, Johnson has provided services to 7,161 Medicare beneficiaries, totaling 14,140 services with total Medicare billing of $787,258. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Columbus, MS
- Active Since 07/27/2006
- Last Updated 01/10/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1083638217
Products in Payments
- STELARA (Biological) $828.15
- DUPIXENT (Biological) $781.52
- RINVOQ (Biological) $498.72
- Humira (Biological) $332.43
- ENTYVIO (Biological) $300.15
- HUMIRA (Biological) $292.52
- XIFAXAN (Drug) $282.61
- VIBERZI (Drug) $271.57
- LINZESS (Drug) $269.73
- ZEPOSIA (Drug) $235.03
- OCALIVA (Drug) $186.90
- DIFICID (Drug) $169.38
- Creon (Drug) $168.90
- Linzess (Drug) $167.28
- TRULANCE (Drug) $160.07
- Entyvio (Biological) $146.02
- ZENPEP (Drug) $143.40
- CREON (Drug) $119.00
- SKYRIZI (Biological) $86.68
- Movantik (Drug) $79.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Columbus
Dr. Lawrence Lynn, Do, DO
Specialist — Payments: $16.3M
Specialist $16.3M
Dr. Dallas Erdmann, Md, MD
Specialist — Payments: $255,768
Specialist $255,768
Dr. Brian Zeno, M.d, M.D
Specialist — Payments: $194,154
Specialist $194,154
Raghu Kolluri, M.d, M.D
Specialist — Payments: $146,032
Specialist $146,032
Victor Dizon, Do, DO
Specialist — Payments: $137,148
Specialist $137,148
Dr. Glen Apseloff, M.d, M.D
Specialist — Payments: $74,569
Specialist $74,569